Comparing needle sizes for prostate MRI-targeted biopsy
Part of Cancer clinical trials.
This study compares two different needle sizes used during a prostate biopsy to see which one finds cancer more accurately and causes fewer side effects. It is for people who have not been diagnosed with prostate cancer before and have a suspicious MRI finding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a high PSA level or an abnormal digital rectal exam that suggests prostate cancer
- An MRI scan found at least one suspicious spot in your prostate (rated PI-RADS 3 or higher)
- You have never been diagnosed with prostate cancer before
- You have never had radiation therapy to the prostate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of taking prostate biopsy samples (TB+PB vs TB+6SB) to see which is better at diagnosing prostate cancer. It is for men who have a suspicious spot on their MRI and meet certain PSA or exam criteria.
This study tests a new, specially designed biopsy needle system against the standard needle system used for prostate biopsies. The researchers will compare how well each system collects tissue samples from men who have suspicious MRI findings, to see if the new needle might give better results.
This trial is testing whether taking extra biopsy samples from specific areas seen on an MRI can better detect prostate cancer compared to the standard method of taking samples from all over the prostate. It may help men who have a suspicious MRI finding and a higher PSA level.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
This trial uses MRI to guide a biopsy of the prostate, aiming to better detect cancer in men with abnormal PSA levels, a lump, or a suspicious MRI finding.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.